Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies
Clinical trial NCT04170283 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04170283
- Sponsor
- BeiGene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2027-11-01
- Enrollment
- 955
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.